Filiz VURAL
Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Anabilim Dalı
Araştırma alanları: Sağlık Bilimleri, Tıp, Dahili Tıp Bilimleri, İç Hastalıkları, Hematoloji, Onkoloji, Temel Tıp Bilimleri, Biyofizik, Temel Bilimler, Yaşam Bilimleri
Yayınlar
- Clinical and Pathological Evaluation of CD5/SOX11 Status in Mantle Cell Lymphoma (2026)
- Evaluation of the Correlation Between Hemoglobin, Albumin, Lymphocyte, and Platelet Score and Prognosis in Patients with Mantle Cell Lymphoma: Single Center Retrospective Study (2026)
- Raccoon eye as the sole presenting sign of AL amyloidosis associated with a low-burden clonal plasma cell neoplasm (2026)
- Antifungal prophylaxis in high-risk patients with hematologic malignancy:a comparison of practice with guidelines in Türkiye (2025)
- Single-center and reverse evaluation of febrile neutropenic attacks of patients followed with acute myeloid leukemia diagnosis (2025)
- Extranodal Nasal-Type NK/T-Cell Lymphoma Treatment: Analysis from a Multicenter Study (2025)
- Evaluation of sleep quality and engraftment in patients undergoing mobilization and hematopoietic stem cell transplantation (2025)
- POSTER: ABCL-373 Retrospecti?ve Analysis of Primary Breast Lymphomas: A Single-Center Experience (2025)
- Otolog Kök Hücre Nakli Yapılan Hastalarda Sitomegalovirüs DNAemisinin Nüks ve Mortalite ile İlişkisi: Tek Merkezli Retrospektif Bir Çalışma (2025)
- Does immunohistochemical staining predict mobilization success in multiple myeloma patients? (2024)
- Long-Term Outcomes of Allogeneic Stem Cell Transplantation for Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma: Multi-center Experience from Turkey (2024)
- Real-Life Experience with Pomalidomide plus Dexamethasone in Patients with Multiple Myeloma: A Single Center Retrospective Study (2024)
- Nodüler Lenfosit Predominant Hodgkin Lenfoma Tedavisinde Rituksimab Temelli Rejimlerin Sağkalıma Katkısı (2024)
- Does immunohistochemical staining predict mobilization success in multiple myeloma patients? (2024)
- A Single-Center Retrospective Evaluation of The Incidence and Survival of Invasive Fungal Infection in Allogeneic Stem Cell Transplant Patients (2024)
- PB1937: A RARE, DIFFICULT- TO- DIAGNOSE DISEASE; LANGERHANS CELL HISTIOCYTOSIS – A SINGLE CENTRE EXPERIENCE (2023)
- POSTER: CT-232 Evaluation of the Effects of Cytomegalovirus and BK Polyomavirus Infections on Overall Survival Following Allogeneic Stem Cell Transplantation: A Single Center Experience (2023)
- POSTER: MDS-145 A Successful Treatment of Relapsed/Refractory MDS Patient who is Followed Under Hemodialysis (2023)
- Eltrombopag for the Treatment of Allogeneic Hematopoietic Stem Cell Transplantation-Related Poor Graft Function (2023)
- POSTER: CT-129 A Rare, Challenging Disease: Langerhans Cell Histiocytosis, a Single-Center Experience (2023)
- POSTER: CT-127 Evaluation of Cytomegalovirus Infection/Disease Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation: A Single Center Experience (2023)
- LONG-TERM OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED/REFRACTORY HODGKIN AND NON-HODGKIN LYMPHOMA: MULTI-CENTER EXPERINCE FROM TURKEY (2023)
- Adult Onset Langerhans Cell Histiocytosis: Clinical Characteristics and Treatment Outcomes (2023)
- Prospective registry of adult patients receiving therapeutic plasma exchange with a presumptive diagnosis of thrombotic microangiopathy (TMA): the Turkish hematology research and education group (ThREG)-TMA02 study (2022)
- Real-Life Experience Regarding Clinical Characteristics and Treatment Outcome in Non-Cutaneous Peripheral T-Cell Lymphomas: A Multicenter Study of the Turkish Hematology Research and Education Group (ThREG) (2022)
- Prophylactic Central Nervous System Irradiation Is Not Indispensable in Adult Patients with Acute Lymphoblastic Leukemia: A Multicenter Retrospective Cohort Study (2022)
- Detailed Analysis of Follicular Lymphoma over 25 Years: A Single-Center, Retrospective Study (2022)
- Withdrawn: Prospective registry of adult patients receiving therapeutic plasma exchange with presumptive diagnosis of thrombotic microangiopathy (TMA): The Turkish hematology research and education group (ThREG)-TMA02 study (2021)
- An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy (2021)
- Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey. (2021)
- Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide‐pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics (2021)
- The Effect of Cryotherapy on the Prevention of Oral Mucositis and on the Oral pH Value in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation (2021)
- Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria with or Without Aplastic Anemia: Multicenter Turkish Experience (2021)
- Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice (2021)
- Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma according to prior lines of treatment and refractory status: ICARIA-MM subgroup analysis (2021)
- APLASTİK ANEMİ İLE BİRLİKTELİĞİ OLAN VE OLMAYAN PNHHASTALARINDA ALLOJENEİK KÖK HÜCRE NAKLİ DENEYİMİ (2020)
- Ege Üniversitesi hastanesi veri tabanında kayıtlı erişkin akut lösemi olgularının epidemiyolojik ve genel sağkalım özelliklerinin retrospektif olarak değerlendirilmesi (2020)
- Real experience of brentuximab vedotin for cutaneous T cell lymphomas (2020)
- Real experience of brentuximab vedotin for cutaneous T cell lymphomas (2020)
- Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma (2020)
- Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of Turkish hematology research and education group (ThREG) (2020)
- Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma (2020)
- Ege Üniversitesi hastanesi veri tabanında kayıtlı erişkin akut lösemi olgularının epidemiyolojik ve genel sağkalım özelliklerinin retrospektif olarak değerlendirilmesi (2020)
- Allogeneic hematopoietic stem cell transplantation in adult aplastic anaemia patients: Promising treatment modality (2019)
- Incidence and risk factors for hepatic sinusoidalobstruction syndrome after allogeneic transplantation:Retrospective multicenter study of Turkish hematologyresearch and education group (THREG), updated data (2019)
- ICARIA-MM study: efficacy analysis according to prior lines of treatment (2019)
- Solid Organ Transplantasyonu Sonrası Post-Transplant Lenfoproliferatif Hastalıklar: Tek Merkez Deneyimi (2019)
- Investigating the cytotoxic and apoptotic effects of sunitinib upon K-562 chronic myelogenous leukemia cell line and assessment of gene profiling (2019)
- Acute lymphoblastic leukemia in routine practice: A Turkish multicenter study (2019)
- Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation (2019)
- Allogeneic stem cell transplantation for acquired pure red cell aplasia (2019)
- Outcome of allogeneic stem cell transplantation for hodgkin and non-hodgkin lymphoma: Single center experince from Turkey (2019)
- Survival outcomes of unrelated donor source: A small retrospective study (2019)
- Retrospective Analysis of Hairy Cell Leukemia Patients Treated with Different Modalities as First Line: Real-Life Experience Over 20 years (2019)
- Solid Organ Transplantasyonu Sonrası Post-Transplant Lenfoproliferatif Hastalıklar: Tek Merkez Deneyimi (2019)
- The Turkish experience with therapeutic plasma exchange: A national survey (2019)
- Outcomes of haploidentical transplantation: A single-center experience from Turkey (2019)
- HODGKİN VE NON-HODGKİN LENFOMADA ALLOJENİK KÖK HÜCRE NAKLİSONUÇLARI: TEK MERKEZ DENEYİMİ (2019)
- Splenic Marginal Zone Lymphoma in Turkey: Association With Hepatitis B Instead Of Hepatitis C Virus As An Etiologic and Possible Prognostic Factor-Multicenter Cohort Study (2019)
- Investigating the cytotoxic and apoptotic effects of sunitinib upon K-562 chronic myelogenous leukemia cell line and assessment of gene profiling (2019)
- Role of Allogeneic Stem Cell Transplant in the Treatment of Primary Myelofibrosis (2019)
- İleri yaş hastalarda allogeneik hematopoetik kök hücre transplantasyonu: Tek merkez deneyimi. (2018)
- CASTLEMAN DISEASE WITH THE EXPERIENCE OVER 17 YEARS (2018)
- BRENTUXIMAB VEDOTIN IN RELAPSED/REFRACTORY HODGKIN`SLYMPHOMA TWO-CENTER IZMIR EXPERIENCE (2018)
- Allogeneic haematopoietic stem cell transplantation in adult aplastic anemia patients (2018)
- Successful Treatment of Patients with AML and MDS by Decitabine: Single Centre Experience (2018)
- Secondary Malignancies in Bcr-Abl Negative Chronic Myeloproliferative Diseases. (2018)
- Cutaneous graft-versus-host disease after hematopoietic stem cell transplantation; a single institution experience (2018)
- Allogeneic Heamatopoietic Stem Cell Transplantation in Elderly Patients; Single Centre Experience (2018)
- DECITABINE TREATMENT IN PATIENTS WITH AML AND MDS SINGLE CENTRE EXPERIENCE (2018)
- Clinical aspects of primary thyroid lymphomas (2018)
- CYTOMEGALOVIRUS INFECTION IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS WITH HEMATOLOGICAL DISEASES: A SINGLE CENTER EXPERIENCE (2018)
- ANALYSIS OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES UNDERGONE STEM CELL TRANSPLANTATION UNDER VORICONAZOLE PROPHYLAXIS (2018)
- Castleman’s Disease with All Aspects: Single Center Experience with Long Term Follow-up (2018)
- Carfilzomib experience in relapsed/refractory multiple myeloma: a single-center experience (2018)
- CYTOMEGALOVIRUS INFECTION IN ALLOGENEIC HEMATOPOIETIC CTEM CELL TRANSPLANT PATIENTS WITH HEMATOLOGICAL DISEASES: A SINGLE CENTER EXPERIENCE (2018)
- Tüm yönleriyle Castleman Hastalığı: 17 yıllık deneyim. (2018)
- Clinical aspects of primary thyroid lymphoma (2018)
- Tüylü hücreli lösemi: İki merkez uzun dönem takip verileri (2018)
- TÜYLÜ HÜCRELİ LÖSEMİ İKİ MERKEZ UZUN DÖNEM TAKİP VERİLERİ (2018)
- The Freqeuency of Ocular GVHD In Patients with Allogeneic Stem Cell Transplantation: A Single Center Experience (2018)
- Successful treatment of patients with AML and MDS by decitabine; single centre experience (2018)
- Akraba dışı allojenik kök hücre nakli ile başarıyla tedavi edilen primer ileal miyeloid sarkom (2018)
- Efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma: a real-life experience (2018)
- LENFOMADA OTOLOG KÖK HÜCRE NAKLİNDE KULLANILANTECAM VE BEAM HAZIRLIK REJİMLERİNİN GERİYE DÖNÜK KARŞILAŞTIRILMASI. (2017)
- KRONİK MYELOPROLİFERATİF NEOPLAZİLİ HASTALARDA RUKSOLİTİNİB ETKİNLİK VE GÜVENLİĞİ: ÇOK MERKEZLİ VE GERİYE DÖNÜK ÇALIŞMA. (2017)
- A RETROSPECTIVE COMPARISON OF TECAM AND BEAM CONDITIONING REGIMENS BEFORE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN LYMPHOMA: EFFICACY AND TOXICITY. (2017)
- EVALUATION OF OUTCOMES OF RESULTS IN PATIENTS WITH CML TREATED WITH SECOND GEN TKIS: EGE HEMATOLOGY EXPERIENCE. (2017)
- POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASES: EGE UNIVERSITY HEMATOLOGY DEPARTMENT’S EXPERIENCE. (2017)
- EFFICACY AND SAFETY OF LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA: A REAL LIFE EXPERIENCE FROM TURKEY. (2017)
- Abnormal cervical cytology and allogeneic stem cell transplantation. (2017)
- TECAM (Thiotepa, Etoposide, Cyclophosphamide, Ara‐c and Melphalan) as conditoning regimen for autologous stem cell transplantation in patients with lymphoma. (2017)
- Neutropenic enterocolitis incidence after autologous stem cell transplantation. (2017)
- Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of Turkish Hematology Research and Education Group (ThREG). (2017)
- A RETROSPECTIVE COMPARISON OF TECAM AND BEAM CONDITIONING REGIMENS BEFORE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN LYMPHOMA: EFFICACY AND TOXICITY (2017)
- TECAM (Thiotepa, Etoposide, Cyclophosphamide, Ara‐c and Melphalan) as conditoning regimen forautologous stem cell transplantation in patients with lymphoma (2017)
- Effect of Different Treatment Patterns to Cost Effectiveness in Chronic Lymphocytic Leukemia Patients, Turkish CLL Study Group (2017)
- A RETROSPECTIVE COMPARISON OF TECAM AND BEAM CONDITIONING REGIMENS BEFORE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN LYMPHOMA: EFFICACY AND TOXICITY (2017)
- Prognostic significance of response status before autologous stem cell transplantation in multiple myeloma patients (2017)
- Multicenter Early Access Program Results from Turkey: Efficacy and Safety of Daratumumab Among Heavily Pretreated Relapse/Refractory Multiple Myeloma Patients (2017)